Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00893386 · ClinicalTrials.gov registry record
Attain StarFix® 4195 Lead Extraction Study
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 227
- Enrollment target
NCT00893386 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 227 participants.
The verdict
NCT00893386 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 227 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the removability of the Attain StarFix® Model 4195 Left Ventricular (LV) Lead (StarFix®). The goal of the trial is to evaluate the lead removal success in patients that are indicated for left ventricular lead removal. This study is required by the Food and Drug Administration (FDA) as a condition of approval for the Attain StarFix® Model 4195 LV Lead.
Interventions
- PROCEDURE LV Lead Extraction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 227 participants |
| Start Date | 2009-07 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00893386
The ClinicalTrials.gov registry entry for NCT00893386 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 227 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LV Lead Extraction is the first listed.
NCT00893386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00893386 about?
NCT00893386 is a clinical study titled "Attain StarFix® 4195 Lead Extraction Study". The purpose of this study is to characterize the removability of the Attain StarFix® Model 4195 Left Ventricular (LV) Lead (StarFix®). The goal of the trial is to evaluate the lead removal success in patients that are indicated for left ventricular lead removal. This study is required by the Food an...
What is the current status of trial NCT00893386?
This trial is currently completed. The enrollment target is 227 participants. The study started on 2009-07. Estimated completion is 2015-04.
What interventions are being tested in trial NCT00893386?
The interventions under investigation include: LV Lead Extraction (PROCEDURE).
Who is sponsoring clinical trial NCT00893386?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.